These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5213)

  • 1. Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine.
    Chelmicka-Szorc E; Arnason BG
    Clin Exp Immunol; 1975 Dec; 22(3):539-45. PubMed ID: 5213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1976 Jul; 117(1):110-4. PubMed ID: 58930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides.
    Raziuddin S; Morrison DC
    J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY; Harvey JM; Webster LT
    J Immunol; 1977 Jun; 118(6):2151-4. PubMed ID: 301156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.
    Mertin J; Stackpoole A
    Clin Exp Immunol; 1979 Jun; 36(3):449-55. PubMed ID: 487646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective action of antioxidant preparations on the development of experimental allergic encephalomyelitis in guinea pigs].
    Kryzhanovskiĭ GN; Vilkov GA; Stepanenko EM
    Biull Eksp Biol Med; 1984 Nov; 98(11):527-30. PubMed ID: 6509167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental allergic encephalomyelitis (EAE) in two inbred guinea pigs. II. Strain differences in susceptibility to passive transfer of EAE.
    Fujiwara S; Fujiwara M; Ohtani S
    Jpn J Exp Med; 1981 Feb; 51(1):17-20. PubMed ID: 7311076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug.
    Kasckow JW; Tabira T; Itoyama Y; Kuroiwa Y; Takenaka A; Nagai Y
    Jpn J Exp Med; 1981 Oct; 51(5):293-8. PubMed ID: 6172610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.
    MacPhee IA; Day MJ; Mason DW
    Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).
    Babington RG; Wedeking PW
    J Pharmacol Exp Ther; 1971 May; 177(2):454-60. PubMed ID: 4254977
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
    J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoluminescent detection of antibodies to testicular antigens in experimental autoimmune orchitis].
    Ogurtsov RP; Zubzhitskii IuN
    Biull Eksp Biol Med; 1979 Dec; 88(12):695-8. PubMed ID: 391295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat.
    Laban O; Marković BM; Dimitrijević M; Janković BD
    Brain Behav Immun; 1995 Mar; 9(1):9-19. PubMed ID: 7542507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA; Leibowitz S
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of experimental allergic encephalomyelitis.
    Arnon R; Teitelbaum D
    Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of experimental allergic encephalomyelitis in rats by suppressor factor from a permanent T cell line.
    Stĕdra J; Holán V; Lodin Z
    Folia Biol (Praha); 1986; 32(3):212-7. PubMed ID: 3488925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.